These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

777 related items for PubMed ID: 19527758

  • 1. Clinical relevance of human leukocyte antigen antibodies in kidney transplantation from deceased donors: the North Italy Transplant program approach.
    Poli F, Cardillo M, Scalamogna M.
    Hum Immunol; 2009 Aug; 70(8):631-5. PubMed ID: 19527758
    [Abstract] [Full Text] [Related]

  • 2. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC, Ozawa M.
    Clin Transpl; 2007 Aug; ():219-26. PubMed ID: 18642453
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Clinical relevance of pretransplant human leukocyte antigen donor-specific antibodies in renal patients waiting for a transplant: a risk factor.
    Gupta A, Sinnott P.
    Hum Immunol; 2009 Aug; 70(8):618-22. PubMed ID: 19374932
    [Abstract] [Full Text] [Related]

  • 6. Donor-reactive HLA antibodies in renal allograft recipients: considerations, complications, and conundrums.
    Gebel HM, Moussa O, Eckels DD, Bray RA.
    Hum Immunol; 2009 Aug; 70(8):610-7. PubMed ID: 19375473
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Anti-HLA antibodies after bone graft and their impact on kidney transplant programs].
    Mosconi G, Baraldi O, Fantinati C, Cappuccilli ML, Corsini S, Zanelli P, Bassi A, Buscaroli B, Feliciangeli G, Stefoni S.
    G Ital Nefrol; 2009 Aug; 26 Suppl 45():S58-63. PubMed ID: 19382096
    [Abstract] [Full Text] [Related]

  • 9. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL, Jin XB, Li XT, Wang HW, Lü JJ.
    Chin Med J (Engl); 2009 Feb 20; 122(4):420-6. PubMed ID: 19302748
    [Abstract] [Full Text] [Related]

  • 10. Relevance of different antibody detection methods for the prediction of antibody-mediated rejection and deceased-donor kidney allograft survival.
    Vlad G, Ho EK, Vasilescu ER, Colovai AI, Stokes MB, Markowitz GS, D'Agati VD, Cohen DJ, Ratner LE, Suciu-Foca N.
    Hum Immunol; 2009 Aug 20; 70(8):589-94. PubMed ID: 19375470
    [Abstract] [Full Text] [Related]

  • 11. Clinical significance of anti-HLA antibodies detected by Luminex: enhancing the interpretation of CDC-BXM and important post-transplantation monitoring tools.
    Eng HS, Bennett G, Bardy P, Coghlan P, Russ GR, Coates PT.
    Hum Immunol; 2009 Aug 20; 70(8):595-9. PubMed ID: 19527759
    [Abstract] [Full Text] [Related]

  • 12. Back to the future: application of contemporary technology to long-standing questions about the clinical relevance of human leukocyte antigen-specific alloantibodies in renal transplantation.
    Taylor CJ, Kosmoliaptsis V, Summers DM, Bradley JA.
    Hum Immunol; 2009 Aug 20; 70(8):563-8. PubMed ID: 19445992
    [Abstract] [Full Text] [Related]

  • 13. Low levels of human leukocyte antigen donor-specific antibodies detected by solid phase assay before transplantation are frequently clinically irrelevant.
    Aubert V, Venetz JP, Pantaleo G, Pascual M.
    Hum Immunol; 2009 Aug 20; 70(8):580-3. PubMed ID: 19375474
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pre- and posttransplant monitoring of alloantibodies by complement-dependent cytotoxicity and luminex methodologies in liver transplantation.
    Monteiro F, Rodrigues H, Kalil J, Castro MC, Panajotopoulos N, Paredes M, Massarolo P, Mies S.
    Transplant Proc; 2012 Oct 20; 44(8):2411-2. PubMed ID: 23026608
    [Abstract] [Full Text] [Related]

  • 16. Cadaver kidney allocation in the north Italy transplant program on the eve of the new millennium.
    Sirchia G, Poli F, Cardillo M, Scalamogna M, Rebulla P, Taioli E, Remuzzi G, Nocera A.
    Clin Transpl; 1998 Oct 20; ():133-45. PubMed ID: 10503092
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A virtual crossmatch protocol significantly increases access of highly sensitized patients to deceased donor kidney transplantation.
    Bingaman AW, Murphey CL, Palma-Vargas J, Wright F.
    Transplantation; 2008 Dec 27; 86(12):1864-8. PubMed ID: 19104435
    [Abstract] [Full Text] [Related]

  • 19. Value of donor-specific antibody detection in first-graft renal transplant recipients with a negative complement-dependent cytotoxic crossmatch.
    Mahmoud KM, Ismail AM, Sheashaa HA, Gheith OA, Kamal MM, Ghoneim MA.
    Exp Clin Transplant; 2009 Jun 27; 7(2):124-8. PubMed ID: 19715518
    [Abstract] [Full Text] [Related]

  • 20. Nebulous humors: defining alloantibodies in the 21st century.
    Warner P.
    Hum Immunol; 2009 Aug 27; 70(8):623-6. PubMed ID: 19374934
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.